Bio Engineered Stent Market
According to Intent Market Research, the Bio Engineered Stent Market is expected to grow from USD 1.2 billion in 2023 at a CAGR of 7.2% to touch USD 1.9 billion by 2030. The Bio Engineered Stent Market is dominated by key players such as, Medtronic plc, Abbott Laboratories, Terumo Corporation, MicroPort Scientific Corporation, and Vascular Solutions, Inc..